Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
vitaliana.desanctis@uniroma1.it
Vitaliana De Sanctis
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
vitaliana.desanctis@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer. a multi-istitutional study
RADIOTHERAPY AND ONCOLOGY
2024
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer
GYNECOLOGIC ONCOLOGY
2024
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy
CLINICAL & EXPERIMENTAL METASTASIS
2024
Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)
LA RADIOLOGIA MEDICA
2024
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer
CANCER DIAGNOSIS & PROGNOSIS
2023
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
JOURNAL OF PERSONALIZED MEDICINE
2023
Vaginal Toxicity Management in Patients with Locally Advanced Cervical Cancer following Exclusive Chemoradiation—A Nationwide Survey on Knowledge and Attitudes by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gynecology Study Group
MEDICINA
2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
CANCERS
2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
JOURNAL OF CLINICAL MEDICINE
2023
Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO)
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
2023
Successful Treatment of a Patient With Breast Implant-Associated Anaplastic Large Cell Lymphoma With Local Residual Disease. A Case Report
ANNALS OF PLASTIC SURGERY
2022
Late Endocrine and Metabolic Sequelae and Long‐Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B‐Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi
CANCERS
2022
Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. A Systematic Review by the Fondazione Italiana Linfomi
CANCERS
2022
Late cardiological sequelae and long-term monitoring in classical hodgkin lymphoma and diffuse large B-cell lymphoma survivors. A systematic review by the fondazione italiana linfomi
CANCERS
2022
Postoperative treatment of intermediate-risk early stage cervical cancer. results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2022
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2022
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
CANCERS
2022
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2021
The impact of healthy lifestyles on late sequelae in classical hodgkin lymphoma and diffuse large b-cell lymphoma survivors. A systematic review by the fondazione italiana linfomi
CANCERS
2021
The role of radiation therapy technologist in interventional radiotherapy (brachytherapy) in Italy: Italian Association of Radiotherapy and Clinical Oncology (AIRO) and Italian Association of Radiation Therapy and Medical Physics Technologists (AITRO) joint project
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2021
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Ruolo del Regorafenib come opzione terapeutica di II linea nelle recidive di glioblastoma: valutazione dei benefici nei pazienti già sottoposti a trattamento radioterapico e chemioterapico con temozolomide.
Impatto della moderna radioterapia sulla sopravvivenza dei pazienti con diagnosi di linfoma (Hodgkin e non Hodgkin) diagnosticati nella Regione Lazio dal 2013 al 2017: un modello epidemiologico real-life.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma